abnormal cellular extravasation_Cdh5<tm6Dvst>/Cdh5<tm6Dvst>

http://metadb.riken.jp/0009858B6CgCdh5tm6DvstCdh5tm6DvstCdh5tm6DvstCdh5tm6Dvst

abnormal cellular extravasation_Cdh5<tm6Dvst>/Cdh5<tm6Dvst>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cadherin 5
  http://metadb.riken.jp/db/mgi_rdf/MGI:105057

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cdh5<tm6Dvst>/Cdh5<tm6Dvst>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cdh5<tm6Dvst>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.Cg-Cdh5<tm6Dvst>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal cellular extravasation
  http://purl.obolibrary.org/obo/MP_0009858

文献

http://purl.org/net/cito/citesAsAuthority

• Florian. Wessel, et.al., Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin., Nature immunology, 2014, 15
  http://rdf.ncbi.nlm.nih.gov/pubmed/24487320